Peter Carroll, MD, MPH

Title(s)Professor, Urology
SchoolSchool of Medicine
Address550 16th Street, #001
San Francisco CA 94158
Phone415-353-7171
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine -Urology
    Memorial Sloan Kettering Cancer Center, NY, NY06/1986Urologic Oncology
    University of California, BerkeleyMPH06/2008
    University of California, San Francisco01/2021Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    My research interests include identifying clinical and pathologic determinants of prostate cancer detection, recurrence, progression, and mortality; discovering novel biomarkers for prostate cancer diagnostics and prognostics, developing evidence-based guidelines for improved management of prostate cancer including surveillance alone, refining the use and outcomes of robotic surgery for prostate cancer, and examining the impact of lifestyle on prostate cancer induction and progression.

    Collapse Research 
    Collapse Research Activities and Funding
    Effectiveness of Early Stage Prostate Cancer Treatment
    NIH RC1CA146596Sep 30, 2009 - Aug 31, 2012
    Role: Principal Investigator
    UCSF KURe Career Development Program
    NIH K12DK083021Sep 30, 2008 - Jul 31, 2020
    Role: Co-Principal Investigator
    Male Reproductive Health Research Career Development Program
    NIH K12HD053943Sep 30, 2006 - Aug 31, 2012
    Role: Principal Investigator
    Active Surveillance for Early Stage Prostate Cancer: Selection, Monitoring
    NIH R13CA121759May 5, 2006 - Apr 30, 2007
    Role: Principal Investigator
    Molecular Effects of Nutrition Supplements in Prostate
    NIH R01CA101042Jun 10, 2003 - May 31, 2009
    Role: Principal Investigator
    UCSF PROSTATE CANCER SPORE
    NIH P50CA089520Sep 25, 2000 - Jun 30, 2010
    Role: Principal Investigator
    Cancer Center Support Grant
    NIH P30CA082103Aug 5, 1999 - May 31, 2023
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Time is on our side - rethinking the concept of time to treatment for prostate cancer. Nat Rev Urol. 2024 Nov 29. Palmer NR, Carroll PR, Washington SL. PMID: 39613985.
      View in: PubMed   Mentions:    Fields:    
    2. Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2024 Oct 09; 101097JU0000000000004265. Fakunle MO, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Carroll PR. PMID: 39383376.
      View in: PubMed   Mentions:    Fields:    
    3. Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life. JAMA Netw Open. 2024 Oct 01; 7(10):e2440747. Patel SA, Patil D, Smith J, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Michalski JM, Wood DP, Hembroff LA, Spratt DE, Wei JT, Sandler HM, Hamstra DA, Pisters L, Kuban D, Regan MM, Wagner A, Crociani CM, Kaplan I, Sanda MG, Chang P, PROST-QA/RP2 Consortium. PMID: 39446326.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Legends in Urology v31I05. Can J Urol. 2024 Oct; 31(5):11974-11976. Carroll PR. PMID: 39462527.
      View in: PubMed   Mentions:    Fields:    
    5. Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance. Eur Urol Oncol. 2024 Sep 27. Shee K, Nie J, Cowan JE, Wang L, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 39341710.
      View in: PubMed   Mentions:    Fields:    
    6. Reevaluating the Definition of "Clinically Significant" Prostate Cancer as Grade Groups 2-5: An Imperative for Improved Risk Stratification. J Urol. 2024 Sep 17; 101097JU0000000000004253. Carlsson SV, Carroll PR, Hamdy FC. PMID: 39288333.
      View in: PubMed   Mentions:    Fields:    
    7. The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI. Magn Reson Imaging. 2024 Dec; 114:110233. Starobinets O, Simko JP, Gibbons M, Kurhanewicz J, Carroll PR, Noworolski SM. PMID: 39260625.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Delayed definitive management of localized prostate cancer: what do we know? Prostate Cancer Prostatic Dis. 2024 Aug 11. Mohamad O, Li YR, Feng F, Hong JC, Wong A, El Kouzi Z, Shelan M, Zilli T, Carroll P, Roach M. PMID: 39128937.
      View in: PubMed   Mentions: 1     Fields:    
    9. Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma. Radiology. 2024 08; 312(2):e232544. Kohlbrenner R, Wu X, Nguyen HG, Cooperberg MR, Chakravarty T, Carroll PR, Hope TA. PMID: 39136560; PMCID: PMC11366670.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    10. De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium. Eur Urol Oncol. 2024 Jul 31. Tohi Y, Sahrmann JM, Arbet J, Kato T, Lee LS, Peacock M, Ginsburg K, Pavlovich C, Carroll P, Bangma CH, Sugimoto M, Boutros PC, Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 39089946.
      View in: PubMed   Mentions:    Fields:    
    11. Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen. JAMA. 2024 07 23; 332(4):335-337. Nik-Ahd F, De Hoedt AM, Butler C, Anger JT, Carroll PR, Cooperberg MR, Freedland SJ. PMID: 38922607; PMCID: PMC11209176.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry. Eur Urol Oncol. 2024 Jul 17. Bangma C, Doan P, Zhu L, Remmers S, Nieboer D, Helleman J, Roobol MJ, Sugimoto M, Chung BH, Lee LS, Frydenberg M, Klotz L, Peacock M, Perry A, Bjartell A, Rannikko A, Van Hemelrijck M, Dasgupta P, Moore C, Trock BJ, Pavlovich C, Steyerberg E, Carroll P, Koo KC, Hayen A, Thompson J, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 39025687.
      View in: PubMed   Mentions:    Fields:    
    13. Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. JAMA. 2024 06 25; 331(24):2084-2093. Newcomb LF, Schenk JM, Zheng Y, Liu M, Zhu K, Brooks JD, Carroll PR, Dash A, de la Calle CM, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, McKenney JK, Morgan TM, Tretiakova MS, Wagner AA, Nelson PS, Lin DW. PMID: 38814624; PMCID: PMC11140579.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage. Histopathology. 2024 Oct; 85(4):598-613. Nguyen JK, Harik LR, Klein EA, Li J, Corrigan D, Liu S, Chan E, Hawley S, Auman H, Newcomb LF, Carroll PR, Cooperberg MR, Filson CP, Simko JP, Nelson PS, Tretiakova MS, Troyer D, True LD, Vakar-Lopez F, Weight CJ, Lin DW, Brooks JD, McKenney JK. PMID: 38828674; PMCID: PMC11365761.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification. Prostate. 2024 Aug; 84(11):1076-1085. Greenland NY, Cooperberg MR, Carroll PR, Cowan JE, Simko JP, Stohr BA, Chan E. PMID: 38734990.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Plant-Based Diets and Disease Progression in Men With Prostate Cancer. JAMA Netw Open. 2024 May 01; 7(5):e249053. Liu VN, Van Blarigan EL, Zhang L, Graff RE, Loeb S, Langlais CS, Cowan JE, Carroll PR, Chan JM, Kenfield SA. PMID: 38691361; PMCID: PMC11063803.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Evaluation of URO17® to improve non-invasive detection of bladder cancer. Urol Oncol. 2024 Jun; 42(6):176.e21-176.e28. Porten SP, Wang EY, Vohra P, Carroll PR, Jahanfard S, Kim NW. PMID: 38553264.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer. Cancer. 2024 May 15; 130(10):1766-1772. Braun AE, Chan JM, Neuhaus J, Cowan JE, Kenfield SA, Van Blarigan EL, Tenggara I, Broering JM, Simko JP, Carroll PR, Cooperberg MR. PMID: 38280206.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker. Sci Rep. 2024 01 04; 14(1):486. Liu S, Hawley SJ, Kunder CA, Hsu EC, Shen M, Westphalen L, Auman H, Newcomb LF, Lin DW, Nelson PS, Feng Z, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Simko J, Gleave ME, Troyer DA, McKenney JK, Brooks JD, Liss MA, Stoyanova T. PMID: 38177207; PMCID: PMC10766957.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study. BMC Cancer. 2023 Dec 05; 23(1):1191. Guan A, Santiago-Rodríguez EJ, Chung BI, Shim JK, Allen L, Kuo MC, Lau K, Loya Z, Brooks JD, Cheng I, DeRouen MC, Frosch DL, Golden T, Leppert JT, Lichtensztajn DY, Lu Q, Oh D, Sieh W, Wadhwa M, Cooperberg MR, Carroll PR, Gomez SL, Shariff-Marco S. PMID: 38053037; PMCID: PMC10696696.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort. Eur Urol Oncol. 2024 Aug; 7(4):838-843. Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 38057193.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel. Eur J Nucl Med Mol Imaging. 2024 Aug; 51(10):2893-2902. Berrens AC, Scheltema M, Maurer T, Hermann K, Hamdy FC, Knipper S, Dell'Oglio P, Mazzone E, de Barros HA, Sorger JM, van Oosterom MN, Stricker PD, van Leeuwen PJ, Rietbergen DDD, Valdes Olmos RA, Vidal-Sicart S, Carroll PR, Buckle T, van der Poel HG, van Leeuwen FWB. PMID: 38012448.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer. Histopathology. 2024 Mar; 84(4):614-623. Greenland NY, Cowan JE, Stohr BA, Simko JP, Carroll PR, Chan E. PMID: 38012532.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial. Eur Urol Oncol. 2024 Jun; 7(3):519-526. Van Blarigan EL, Kenfield SA, Olshen A, Panchal N, Encabo K, Tenggara I, Graff RE, Bang AS, Shinohara K, Cooperberg MR, Carroll PR, Jones LW, Winters-Stone K, Luke A, Chan JM. PMID: 37907387.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. What is the most effective and safest Non-steroidal anti-inflammatory drug for treating osteoarthritis in patients with comorbidities? Expert Opin Drug Metab Toxicol. 2023 Jul-Dec; 19(10):681-695. Geczy QE, Thirumaran AJ, Carroll PR, McLachlan AJ, Hunter DJ. PMID: 37817419.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2024 Jun; 85(6):565-573. Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR. PMID: 37858454.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. Ten-year work burden after prostate cancer treatment. Cancer Med. 2023 Sep; 12(18):19234-19244. Washington SL, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR. PMID: 37724617; PMCID: PMC10557888.
      View in: PubMed   Mentions: 1     Fields:    
    28. Editorial Comment. Urol Pract. 2023 09; 10(5):422. Carroll PR. PMID: 37594039.
      View in: PubMed   Mentions:    Fields:    
    29. First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy. Eur Urol Oncol. 2024 Feb; 7(1):63-72. Nguyen HG, van den Berg NS, Antaris AL, Xue L, Greenberg S, Rosenthal JW, Muchnik A, Klaassen A, Simko JP, Dutta S, Sorger JM, Munster P, Carroll PR. PMID: 37516587.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy. Eur Urol Focus. 2024 Jan; 10(1):66-74. Sabbagh A, Tilki D, Feng J, Huland H, Graefen M, Wiegel T, Böhmer D, Hong JC, Valdes G, Cowan JE, Cooperberg M, Feng FY, Mohammad T, Shelan M, D'Amico AV, Carroll PR, Mohamad O. PMID: 37507248.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial. Eur Urol. 2023 12; 84(6):588-596. Djaïleb L, Armstrong WR, Thompson D, Gafita A, Farolfi A, Rajagopal A, Grogan TR, Nguyen K, Benz MR, Hotta M, Barbato F, Ceci F, Schwarzenböck SM, Unterrainer M, Zacho HD, Juarez R, Cooperberg M, Carroll P, Washington S, Reiter RE, Eiber M, Herrmann K, Fendler WP, Czernin J, Hope TA, Calais J. PMID: 37482512.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    32. Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. Eur Urol Oncol. 2024 Apr; 7(2):222-230. Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR. PMID: 37474400.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    33. Explainable ML models for a deeper insight on treatment decision for localized prostate cancer. Sci Rep. 2023 07 17; 13(1):11532. Han JH, Lee S, Lee B, Baek OK, Washington SL, Herlemann A, Lonergan PE, Carroll PR, Jeong CW, Cooperberg MR. PMID: 37460568; PMCID: PMC10352331.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Impact of Stress Urinary Incontinence After Radical Prostatectomy on Time to Intervention, Quality of Life and Work Status. Urology. 2023 Oct; 180:242-248. Braun AE, Washington SL, Cowan JE, Hampson LA, Carroll PR. PMID: 37442296.
      View in: PubMed   Mentions: 3     Fields:    
    35. Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies. Support Care Cancer. 2023 Jul 10; 31(8):453. Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA. PMID: 37428241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Urol Oncol. 2023 10; 41(10):429.e9-429.e14. Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR. PMID: 37407420.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study. Mod Pathol. 2023 Oct; 36(10):100241. Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, Newcomb LF, Lin DW, Nelson PS, Feng Z, Boyer HD, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Cooperberg MR, Chan E, Simko J, Fazli L, Gleave M, Hurtado-Coll A, Thompson IM, Troyer D, McKenney JK, Wei W, Choyke PL, Bratslavsky G, Turkbey B, Siemens DR, Squire J, Peng YP, Brooks JD, Jamaspishvili T. PMID: 37343766; PMCID: PMC10592257.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022. JAMA. 2023 06 06; 329(21):1877-1879. Nik-Ahd F, De Hoedt A, Butler C, Anger JT, Carroll PR, Cooperberg MR, Freedland SJ. PMID: 37119522; PMCID: PMC10148974.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer. Urology. 2023 08; 178:114-119. Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR. PMID: 37244430.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality. Br J Cancer. 2023 08; 129(2):346-355. Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM. PMID: 37217583; PMCID: PMC10338438.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin. Clin Genitourin Cancer. 2023 10; 21(5):e394-e404. Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal R, Small EJ, Fong L, Chou J, Friedlander T, de Kouchkovsky I, Koshkin VS. PMID: 37316414.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. A Novel Standardized Morbidity and Mortality Process to Promote Discourse, Improve Education, and Facilitate Practice Change: The M-PROVE Model. Urol Pract. 2023 07; 10(4):391-397. Bowman M, Yang H, Ahn J, Carroll PR, Hampson LA. PMID: 37228231.
      View in: PubMed   Mentions:    Fields:    
    43. Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging. J Urol. 2023 08; 210(2):281-289. Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carroll PR, Cooperberg MR. PMID: 37099018.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    44. PSA density does not improve predictive accuracy of the UCSF-CAPRA score. Prostate. 2023 07; 83(10):922-928. Parker R, Bell A, Chang K, Greenberg S, Washington SL, Cowan JE, Carroll PR, Cooperberg MR. PMID: 37078628.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system's electronic medical record? J Sex Med. 2023 03 31; 20(4):559-567. Nik-Ahd F, Waller J, De Hoedt AM, Garcia MM, Figueiredo JC, Carroll PR, Cooperberg MR, Freedland SJ. PMID: 36814112.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States. World J Mens Health. 2023 Oct; 41(4):940-950. Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW. PMID: 37118954; PMCID: PMC10523124.
      View in: PubMed   Mentions: 2  
    47. Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort. Eur Urol. 2023 07; 84(1):9-12. Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 36870794.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol. 2023 05 01; 41(13):2428-2435. Tilki D, Chen MH, Wu J, Huland H, Graefen M, Mohamad O, Cowan JE, Feng FY, Carroll PR, D'Amico AV. PMID: 36857638; PMCID: PMC10150889.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    49. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Eur Urol Oncol. 2023 Oct; 6(5):501-507. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. PMID: 36868922.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. The natural history of a delayed detectable PSA after radical prostatectomy. Prostate Cancer Prostatic Dis. 2023 Dec; 26(4):759-764. Szymaniak JA, Washington SL, Cowan JE, Cooperberg MR, Lonergan PE, Nguyen HG, Meng MV, Carroll PR. PMID: 36765111; PMCID: PMC10638081.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard. Magn Reson Imaging. 2023 06; 99:48-57. Gibbons M, Simko JP, Carroll PR, Noworolski SM. PMID: 36641104; PMCID: PMC11229728.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II). Contemp Clin Trials. 2023 02; 125:107079. Van Blarigan EL, Chan JM, Sanchez A, Zhang L, Winters-Stone K, Liu V, Macaire G, Panchal N, Graff RE, Tenggara I, Luke A, Simko JP, Cooperberg MR, Carroll PR, Kenfield SA. PMID: 36621597.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    53. Use of Voice Recordings in the Consultation of Patients Seeking Genital Gender-Affirming Surgery: An Opportunity for Broader Application Throughout Surgery? J Surg Res (Houst). 2022; 5(4):618-625. Smith SM, Stelmar J, Lee G, Carroll PR, Garcia MM. PMID: 36643404; PMCID: PMC9836232.
      View in: PubMed   Mentions: 3  
    54. Health Literacy and Appropriateness of Self-Care and Pain Management in Osteoarthritis: An Understanding of the Patient's Perspective. Arthritis Care Res (Hoboken). 2023 04; 75(4):848-859. Hunter DJ, McLachlan AJ, Carroll PR, Wakefield TAN, Stosic R. PMID: 34941010.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer. Cancer Med. 2023 03; 12(5):6307-6317. Guan A, Shim JK, Allen L, Kuo MC, Lau K, Loya Z, Brooks JD, Carroll PR, Cheng I, Chung BI, DeRouen MC, Frosch DL, Golden T, Leppert JT, Lichtensztajn DY, Lu Q, Oh DL, Sieh W, Wadhwa M, Gomez SL, Shariff-Marco S. PMID: 36404625; PMCID: PMC10028041.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study. Nutr Cancer. 2023; 75(2):618-626. Schenk JM, Liu M, Neuhouser ML, Newcomb LF, Zheng Y, Zhu K, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Wagner AA, Lin DW. PMID: 36343223; PMCID: PMC9974882.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Prostate-Specific Antigen Screening in Transgender Patients. Eur Urol. 2023 Jan; 83(1):48-54. Nik-Ahd F, Jarjour A, Figueiredo J, Anger JT, Garcia M, Carroll PR, Cooperberg MR, Vidal AC, Freedland SJ. PMID: 36344317.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula. Eur J Epidemiol. 2022 Dec; 37(12):1205-1213. Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA. PMID: 36289138.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence. Eur J Cancer Care (Engl). 2022 Nov; 31(6):e13740. Weng X, Zhong L, Xiang P, Li Y, Paciorek A, Dong L, Broering J, Carroll PR, Sanda M, Wilson L. PMID: 36239065.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading, but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. Reply. J Urol. 2023 01; 209(1):73. Carroll P. PMID: 36484446.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. J Urol. 2023 01; 209(1):198-207. Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 36067374.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality. Cancer Epidemiol Biomarkers Prev. 2022 09 02; 31(9):1760-1768. Langlais CS, Graff RE, Van Blarigan EL, Kenfield SA, Neuhaus J, Tabung FK, Cowan JE, Broering JM, Carroll P, Chan JM. PMID: 35767977; PMCID: PMC9444922.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    63. Risk of progression following a negative biopsy in prostate cancer active surveillance. Prostate Cancer Prostatic Dis. 2023 06; 26(2):403-409. Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A, Bjartell A, Morgan T, Dasgupta P, Van Hemelrijck M, Elhage O, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 36008540; PMCID: PMC10247354.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue. Urology. 2022 12; 170:154-160. Andolfi C, Vickers AJ, Cooperberg MR, Carroll PR, Cowan JE, Paner GP, Helfand BT, Liauw SL, Eggener SE. PMID: 35987380; PMCID: PMC10515713.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    65. Adverse Pathological Findings at Radical Prostatectomy following Active Surveillance: Results from the Movember GAP3 Cohort. Cancers (Basel). 2022 07 22; 14(15). Marenghi C, Qiu Z, Helleman J, Nieboer D, Rubio-Briones J, Carroll PR, Lee LS, Valdagni R, Boutros PC, Nicolai N, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 35892817; PMCID: PMC9332009.
      View in: PubMed   Mentions: 1  
    66. Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease. Urol Oncol. 2022 10; 40(10):451.e15-451.e20. Baskin A, Charondo LB, Balakrishnan A, Cowan JE, Cooperberg MR, Carroll PR, Nguyen H, Shinohara K. PMID: 35851186.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    67. Patient engagement in a mobile health intervention to improve preparedness for prostate biopsy. Urol Oncol. 2022 09; 40(9):407.e1-407.e7. Balakrishnan AS, Nguyen HG, Shinohara K, Carroll PR, Odisho AY. PMID: 35840464.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance. J Urol. 2022 11; 208(5):1037-1045. Filson CP, Zhu K, Huang Y, Zheng Y, Newcomb LF, Williams S, Brooks JD, Carroll PR, Dash A, Ellis WJ, Gleave ME, Liss MA, Martin F, McKenney JK, Morgan TM, Wagner AA, Sokoll LJ, Sanda MG, Chan DW, Lin DW. PMID: 35830553; PMCID: PMC10189606.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. Development and Service Evaluation of an ad hoc Virtual Arthroplasty Clinic during COVID-19: Experiences from Irish National Orthopaedic Hospital. Malays Orthop J. 2022 Jul; 16(2):46-54. Murphy B, Carroll P, Daly R, McLaverty A, Keogh P, O'Byrne J, Cashman J. PMID: 35992987; PMCID: PMC9388817.
      View in: PubMed   Mentions:
    70. Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative. Eur Urol Open Sci. 2022 Jul; 41:126-133. Remmers S, Helleman J, Nieboer D, Trock B, Hyndman ME, Moore CM, Gnanapragasam V, Shiong Lee L, Elhage O, Klotz L, Carroll P, Pickles T, Bjartell A, Robert G, Frydenberg M, Sugimoto M, Ehdaie B, Morgan TM, Rubio-Briones J, Semjonow A, Bangma CH, Roobol MJ, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 35813247; PMCID: PMC9257656.
      View in: PubMed   Mentions: 2  
    71. Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance. Cancer Med. 2022 11; 11(22):4332-4340. Brady L, Newcomb LF, Zhu K, Zheng Y, Boyer H, Sarkar N, McKenney JK, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, Morgan TM, Thompson IM, Wagner AA, Pritchard CC, Lin DW, Nelson PS. PMID: 35467778; PMCID: PMC9678104.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. Editorial Comment. J Urol. 2022 07; 208(1):108. Carroll PR. PMID: 35450426.
      View in: PubMed   Mentions:    Fields:    
    73. The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy. Prostate Cancer Prostatic Dis. 2022 02; 25(2):344-350. Greenberg SA, Cowan JE, Lonergan PE, Washington SL, Nguyen HG, Zagoria RJ, Carroll PR. PMID: 35352026.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    74. Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial. Adv Radiat Oncol. 2022 Sep-Oct; 7(5):100941. Shee K, de la Calle CM, Chang AJ, Wong AC, Feng FY, Gottschalk AR, Carroll PR, Nguyen HG. PMID: 35847550; PMCID: PMC9280039.
      View in: PubMed   Mentions: 4  
    75. Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database. Prostate. 2022 05; 82(7):876-879. Beckmann KR, Bangma CH, Helleman J, Bjartell A, Carroll PR, Morgan T, Nieboer D, Santaolalla A, Trock BJ, Valdagni R, Roobol MJ, Global Action Plan Active Surveillance Prostate Cancer [G.A.P.3] Consortium. PMID: 35254666; PMCID: PMC9541488.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    76. Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis. Hum Pathol. 2022 04; 122:84-91. Ruder S, Gao Y, Ding Y, Bu P, Miles B, De Marzo A, Wheeler T, McKenney JK, Auman H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Platz E, Trock B, Han M, Sayeeduddin M, True LD, Rowley D, Lin DW, Nelson PS, Thompson IM, Feng Z, Wei W, Brooks JD, Ittmann M, Lee M, Ayala G. PMID: 35176252; PMCID: PMC9832989.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma. Mod Pathol. 2022 08; 35(8):1092-1100. Chan E, McKenney JK, Hawley S, Corrigan D, Auman H, Newcomb LF, Boyer HD, Carroll PR, Cooperberg MR, Klein E, Fazli L, Gleave ME, Hurtado-Coll A, Simko JP, Nelson PS, Thompson IM, Tretiakova MS, Troyer D, True LD, Vakar-Lopez F, Lin DW, Brooks JD, Feng Z, Nguyen JK. PMID: 35145197; PMCID: PMC9314256.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    78. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat Commun. 2022 01 10; 13(1):141. Song H, Weinstein HNW, Allegakoen P, Wadsworth MH, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY, Carroll PR, Wang B, Cooperberg MR, Shalek AK, Huang FW. PMID: 35013146; PMCID: PMC8748675.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    79. Osteoarthritis management: Does the pharmacist play a role in bridging the gap between what patients actually know and what they ought to know? Insights from a national online survey. Health Expect. 2022 06; 25(3):936-946. McLachlan AJ, Carroll PR, Hunter DJ, Wakefield TAN, Stosic R. PMID: 34997667; PMCID: PMC9122430.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2022 05; 207(5):1001-1009. Chappidi MR, Bell A, Cowan JE, Greenberg SA, Lonergan PE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 34981949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    81. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Eur Urol Open Sci. 2022 Jan; 35:59-67. Olivier J, Li W, Nieboer D, Helleman J, Roobol M, Gnanapragasam V, Frydenberg M, Sugimoto M, Carroll P, Morgan TM, Valdagni R, Rubio-Briones J, Robert G, Stricker P, Hayen A, Schoots I, Haider M, Moore CM, Denton B, Villers A, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 Consortium. PMID: 35024633; PMCID: PMC8738894.
      View in: PubMed   Mentions: 5  
    82. Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer. Investig Clin Urol. 2022 01; 63(1):27-33. Greenland NY, Cooperberg MR, Wong AC, Chan E, Carroll PR, Simko JP, Stohr BA. PMID: 34983120; PMCID: PMC8756156.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    83. Development and evaluation of an interprofessional student-led influenza vaccination clinic for medical, nursing and pharmacy students. Pharm Pract (Granada). 2021 Oct-Dec; 19(4):2449. Carroll PR, Hanrahan J. PMID: 35474645; PMCID: PMC9013193.
      View in: PubMed   Mentions: 5  
    84. Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort. J Urol. 2022 04; 207(4):805-813. Waisman Malaret AJ, Chang P, Zhu K, Zheng Y, Newcomb LF, Liu M, McKenney JK, Brooks JD, Carroll P, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Lin DW, Wagner AA. PMID: 34854745; PMCID: PMC8917057.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    85. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. J Urol. 2022 04; 207(4):832-840. Lonergan PE, Washington SL, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR. PMID: 34854749.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    86. Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. HGG Adv. 2022 Jan 13; 3(1). Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N, Logothetis CJ, Gregg JR, Perez CA, Garza S, Kim J, Marks LS, Delfin M, Barsa D, Vesprini D, Klotz LH, Loblaw A, Mamedov A, Goldenberg SL, Higano CS, Spillane M, Wu E, Carter HB, Pavlovich CP, Mamawala M, Landis T, Carroll PR, Chan JM, Cooperberg MR, Cowan JE, Morgan TM, Siddiqui J, Martin R, Klein EA, Brittain K, Gotwald P, Barocas DA, Dallmer JR, Gordetsky JB, Steele P, Kundu SD, Stockdale J, Roobol MJ, Venderbos LDF, Sanda MG, Arnold R, Patil D, Evans CP, Dall'Era MA, Vij A, Costello AJ, Chow K, Corcoran NM, Rais-Bahrami S, Phares C, Scherr DS, Flynn T, Karnes RJ, Koch M, Dhondt CR, Nelson JB, McBride D, Cookson MS, Stratton KL, Farriester S, Hemken E, Stadler WM, Pera T, Banionyte D, Bianco FJ, Lopez IH, Loeb S, Taneja SS, Byrne N, Amling CL, Martinez A, Boileau L, Gaylis FD, Petkewicz J, Kirwen N, Helfand BT, Xu J, Scholtens DM, Catalona WJ, Witte JS. PMID: 34993496; PMCID: PMC8725988.
      View in: PubMed   Mentions: 12     Fields:    
    87. Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database. Eur Urol Open Sci. 2021 Dec; 34:47-54. Beckmann K, Santaolalla A, Helleman J, Carroll P, Ha Chung B, Shiong Lee L, Perry A, Rubio-Briones J, Sugimoto M, Trock B, Valdagni R, Dasgupta P, Van Hemelrijck M, Elhage O, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. PMID: 34934967; PMCID: PMC8655390.
      View in: PubMed   Mentions:
    88. Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial. JAMA Oncol. 2021 Nov 01; 7(11):1635-1642. Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, Reiter RE, Holden S, Herrmann K, Zhu S, Fendler WP, Czernin J, Calais J. PMID: 34529005; PMCID: PMC8446902.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCTClinical Trials
    89. Identification of prostate cancer using multiparametric MR imaging characteristics of prostate tissues referenced to whole mount histopathology. Magn Reson Imaging. 2022 01; 85:251-261. Gibbons M, Starobinets O, Simko JP, Kurhanewicz J, Carroll PR, Noworolski SM. PMID: 34666162; PMCID: PMC9931199.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    90. Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. Cancer. 2022 Jan 15; 128(2):269-274. Kirk PS, Zhu K, Zheng Y, Newcomb LF, Schenk JM, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss M, Martin F, McKenney JK, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Gore JL. PMID: 34516660; PMCID: PMC8738121.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    91. Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database. Prostate Cancer Prostatic Dis. 2022 04; 25(4):690-693. Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 34508180; PMCID: PMC9705238.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    92. Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium. J Urol. 2022 01; 207(1):127-136. Chang P, Wagner AA, Regan MM, Smith JA, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Partin AW, Wood DP, Crociani CM, Greenfield TK, Patil D, Hembroff LA, Davis K, Stork L, Spratt DE, Wei JT, Sanda MG, PROST-QA/RP2 Consortium. PMID: 34433304; PMCID: PMC8840795.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    93. Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume. Urology. 2021 11; 157:102-106. Vertosick EA, Zappala S, Punnen S, Hugosson J, Boorjian SA, Haese A, Carroll P, Cooperberg M, Bjartell A, Lilja H, Vickers AJ. PMID: 34450175; PMCID: PMC8671182.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort. Prostate. 2021 09; 81(13):1009-1017. Lonergan PE, Cowan JE, Washington SL, Greenberg SA, Nguyen HG, Carroll PR. PMID: 34288004.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort. Urol Pract. 2021 Sep; 8(5):576-582. Waisman Malaret AJ, Chang P, Newcomb L, Faino A, Zheng Y, Zhu K, McKenney JK, Brooks JD, Dash A, Ellis WJ, Filson CP, Gleave M, Liss M, Martin FM, Morgan T, Carroll P, Nelson P, Lin DW, Wagner AA. PMID: 37145399.
      View in: PubMed   Mentions:    Fields:    
    96. Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance. Urology. 2021 09; 155:91-95. de la Calle CM, Shee K, Chu CE, Cowan JE, Nguyen HG, Carroll PR. PMID: 34118228.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    97. A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria? Eur J Nucl Med Mol Imaging. 2021 12; 48(13):4463-4471. Salavati A, Gencturk M, Koksel Y, Schik AN, Carroll PR, Feng FY, Rowe SP, Lawhn-Heath C, Hope TA, Froelich JW. PMID: 34091713.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    98. Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol. 2021 07 10; 39(20):2284-2293. Tilki D, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Mohamad O, Cowan JE, Feng FY, Carroll PR, Trock BJ, Partin AW, D'Amico AV. PMID: 34086480.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    99. Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen. J Urol. 2021 09; 206(3):706-714. Greenberg SA, Washington SL, Lonergan PE, Cowan JE, Baskin AS, Nguyen HG, Odisho AY, Simko JP, Carroll PR. PMID: 33905262.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    100. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing. JCO Precis Oncol. 2021; 5. Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Kageyama R, Wells DK, Chan JM, Friedlander T, Aggarwal R, Paris PL, Feng F, Carroll PR, Witte JS. PMID: 34250416; PMCID: PMC8232833.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    101. SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study. Cancers (Basel). 2021 Apr 23; 13(9). Maggi M, Del Giudice F, Falagario UG, Cocci A, Russo GI, Di Mauro M, Sepe GS, Galasso F, Leonardi R, Iacona G, Carroll PR, Cooperberg MR, Porreca A, Ferro M, Lucarelli G, Terracciano D, Cormio L, Carrieri G, De Berardinis E, Sciarra A, Busetto GM. PMID: 33922626; PMCID: PMC8122883.
      View in: PubMed   Mentions: 30  
    102. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes. Int J Mol Sci. 2021 Apr 22; 22(9). Salciccia S, Capriotti AL, Laganà A, Fais S, Logozzi M, De Berardinis E, Busetto GM, Di Pierro GB, Ricciuti GP, Del Giudice F, Sciarra A, Carroll PR, Cooperberg MR, Sciarra B, Maggi M. PMID: 33922033; PMCID: PMC8122596.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    103. Reply by Authors. J Urol. 2021 07; 206(1):61. Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ. PMID: 33853358.
      View in: PubMed   Mentions: 1     Fields:    
    104. Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history. Cancer Causes Control. 2021 Jun; 32(6):635-644. Langlais CS, Chan JM, Kenfield SA, Cowan JE, Graff RE, Broering JM, Carroll P, Van Blarigan EL. PMID: 33837499; PMCID: PMC8189293.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    105. Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer. Eur Urol. 2021 06; 79(6):717-721. Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, Carroll PR, Schaeffer E, Feng FY. PMID: 33840559.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    106. Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter. J Urol. 2021 07; 206(1):171-172. Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ. PMID: 33818133.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    107. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Reply. J Urol. 2021 07; 206(1):174. Carroll PR, Maggi M. PMID: 33683938.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    108. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. Urol Oncol. 2021 11; 39(11):781.e17-781.e24. Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF, George AK, Gill IS, Gupta RT, Katz AE, Lebastchi AH, Marks LS, Marra G, Pinto PA, Song DY, Sidana A, Ward JF, Sanchez-Salas R, Rosette J, Polascik TJ, Focal Therapy Group Authors. PMID: 33676851; PMCID: PMC8654321.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    109. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer. Sci Rep. 2021 03 03; 11(1):5040. Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Chu C, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Chan JM, Friedlander T, Wyatt AW, Aggarwal R, Paris PL, Carroll PR, Feng F, Witte JS. PMID: 33658587; PMCID: PMC7930042.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    110. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY). J Urol. 2021 07; 206(1):52-61. Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ. PMID: 33634707; PMCID: PMC8556578.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansCTClinical Trials
    111. Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study. Clin Cancer Res. 2021 07 01; 27(13):3674-3682. Morris MJ, Rowe SP, Gorin MA, Saperstein L, Pouliot F, Josephson D, Wong JYC, Pantel AR, Cho SY, Gage KL, Piert M, Iagaru A, Pollard JH, Wong V, Jensen J, Lin T, Stambler N, Carroll PR, Siegel BA, CONDOR Study Group. PMID: 33622706; PMCID: PMC8382991.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCTClinical Trials
    112. A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance. BMC Urol. 2021 Feb 04; 21(1):18. Merriel SWD, Moon D, Dundee P, Corcoran N, Carroll P, Partin A, Smith JA, Hamdy F, Moore C, Ost P, Costello T. PMID: 33541309; PMCID: PMC7863517.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    113. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2022 10; 5(5):537-543. Chu CE, Cowan JE, Lonergan PE, Washington SL, Fasulo V, de la Calle CM, Shinohara K, Westphalen AC, Carroll PR. PMID: 33483265.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    114. Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial. J Med Internet Res. 2020 12 31; 22(12):e19238. Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM. PMID: 33382378; PMCID: PMC7808895.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    115. Editorial Comment. J Urol. 2021 03; 205(3):777-778. Carroll PR. PMID: 33355500.
      View in: PubMed   Mentions:    Fields:    
    116. Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease. Sci Rep. 2020 12 10; 10(1):21750. Smith R, Liu M, Liby T, Bayani N, Bucher E, Chiotti K, Derrick D, Chauchereau A, Heiser L, Alumkal J, Feiler H, Carroll P, Korkola JE. PMID: 33303959; PMCID: PMC7729982.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    117. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. Eur Urol. 2021 03; 79(3):374-383. Jairath NK, Dal Pra A, Vince R, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, Morgan TM, Weiner AB, Mohamad O, Carroll PR, Cooperberg MR, Karnes RJ, Nguyen PL, Michalski JM, Tward JD, Feng FY, Schaeffer EM, Spratt DE. PMID: 33293078.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    118. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 Mar; 149:168-173. Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. PMID: 33278460.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    119. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US. JAMA Netw Open. 2020 12 01; 3(12):e2031349. Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 33369661; PMCID: PMC7770559.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    120. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. JAMA Oncol. 2020 12 01; 6(12):1912-1920. Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, DeWeese TL, Greco S, McNutt TR, Song DY, Sun Y, Mehra R, Kaffenberger SD, Morgan TM, Nguyen PL, Feng FY, Sharma V, Tran PT, Stish BJ, Pisansky TM, Zaorsky NG, Moraes FY, Berlin A, Finelli A, Fossati N, Gandaglia G, Briganti A, Carroll PR, Karnes RJ, Kattan MW, Schipper MJ, Spratt DE. PMID: 33090219; PMCID: PMC7582232.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    121. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer. J Urol. 2021 Apr; 205(4):1047-1054. Cullen J, Lynch JA, Klein EA, Van Den Eeden SK, Carroll PR, Mohler JL, Knezevic D, Farrington TA, Lu R. PMID: 33493001.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    122. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide? J Urol. 2021 Jan; 205(1):109-114. Chu CE, Cowan JE, Fasulo V, Washington SL, de la Calle C, Shoemaker J, Carroll PR. PMID: 33198555.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    123. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1222-1228. Maggi M, Cowan JE, Fasulo V, Washington SL, Lonergan PE, Sciarra A, Nguyen HG, Carroll PR. PMID: 33157570.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    124. Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies. Cancer Med. 2020 12; 9(24):9611-9619. Li W, Denton BT, Nieboer D, Carroll PR, Roobol MJ, Morgan TM, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. PMID: 33159431; PMCID: PMC7774732.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    125. Reply by Authors. J Urol. 2021 02; 205(2):339-340. Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PMID: 33155864.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    126. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes. Eur Urol. 2021 01; 79(1):141-149. Cooperberg MR, Cowan JE, Lindquist KJ, Kobayashi Y, Simko JP, Bengtsson H, Singh K, Ngo V, Avila A, Newcomb LF, Tretriakova M, Lin DW, Stone S, Carroll PR, Paris PL. PMID: 33148472.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    127. Editorial Comment. J Urol. 2021 Jan; 205(1):121. Chu C, Carroll P. PMID: 33136472.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    128. Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate. JCO Precis Oncol. 2020 Nov; 4:1228-1238. Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, Tosoian JJ, Morgan TM, Mehra R, Salami SS, Nguyen PL, Lawton CAF, Spratt DE, Feng F. PMID: 35050780.
      View in: PubMed   Mentions: 4     Fields:    
    129. Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic Review. JAMA Oncol. 2020 Nov 01; 6(11):1793-1800. Sachdev S, Carroll P, Sandler H, Nguyen PL, Wafford E, Auffenberg G, Schaeffer E, Roach M, Evans CP, Hussain M. PMID: 32852528.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    130. Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer. Prostate. 2021 02; 81(2):102-108. Washington SL, Cowan JE, Herlemann A, Zuniga KB, Masic S, Nguyen HG, Carroll PR. PMID: 33075151.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    131. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. Eur Urol Oncol. 2022 02; 5(1):61-69. Fasulo V, Cowan JE, Maggi M, Washington SL, Nguyen HG, Shinohara K, Lazzeri M, Casale P, Carroll PR. PMID: 33069628.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    132. Natural language processing systems for pathology parsing in limited data environments with uncertainty estimation. JAMIA Open. 2020 Oct; 3(3):431-438. Odisho AY, Park B, Altieri N, DeNero J, Cooperberg MR, Carroll PR, Yu B. PMID: 33381748; PMCID: PMC7751177.
      View in: PubMed   Mentions: 7  
    133. Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability. JAMA Oncol. 2020 10 01; 6(10):e203187. Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, Brooks JD, Dash A, Gleave ME, Martin F, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Carroll PR, Lin DW. PMID: 32852532; PMCID: PMC7453344.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    134. Student-led interprofessional influenza vaccination clinic in a time of coronavirus. Med Educ. 2020 11; 54(11):1078-1079. Hanrahan JR, Carroll PR. PMID: 32984968; PMCID: PMC7537206.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    135. Reply by Authors. J Urol. 2020 12; 204(6):1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32969756.
      View in: PubMed   Mentions:    Fields:    
    136. Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. Prostate. 2020 12; 80(16):1421-1428. Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP. PMID: 32946625.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    137. Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer. J Urol. 2021 02; 205(2):452-460. de la Calle CM, Fasulo V, Cowan JE, Lonergan PE, Maggi M, Gadzinski AJ, Yeung RA, Saita A, Cooperberg MR, Shinohara K, Carroll PR, Nguyen HG. PMID: 32897802.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    138. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer. BMC Cancer. 2020 Aug 28; 20(1):820. Cario CL, Chen E, Leong L, Emami NC, Lopez K, Tenggara I, Simko JP, Friedlander TW, Li PS, Paris PL, Carroll PR, Witte JS. PMID: 32859160; PMCID: PMC7456018.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    139. How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? Eur Urol Focus. 2021 Nov; 7(6):1268-1273. Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR. PMID: 32868222.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    140. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Eur J Nucl Med Mol Imaging. 2021 02; 48(2):501-508. Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, PSMA PET Reader Group, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin J, Hope TA. PMID: 32808077; PMCID: PMC7835157.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    141. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry. Urol Oncol. 2020 10; 38(10):793.e1-793.e11. Borno HT, Cowan JE, Zhao S, Broering JM, Carroll PR, Ryan CJ. PMID: 32782182.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    142. Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis. J Med Internet Res. 2020 07 06; 22(7):e19322. Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, Odisho AY. PMID: 32568721; PMCID: PMC7340164.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCellsPHPublic Health
    143. Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. Eur Urol. 2020 10; 78(4):515-517. Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR. PMID: 32631744.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    144. Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51. Eur Urol. 2020 09; 78(3):e110-e111. Chu CE, Lonergan PE, Carroll PR. PMID: 32622551.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    145. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1216-1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32519915.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    146. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 08 20; 38(24):2798-2811. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. PMID: 32516092; PMCID: PMC7430215.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    147. The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer. JNCI Cancer Spectr. 2020 Oct; 4(5):pkaa044. Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. PMID: 33134826; PMCID: PMC7583149.
      View in: PubMed   Mentions:    Fields:    
    148. Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. J Nucl Med. 2020 12; 61(12):1793-1799. Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA. PMID: 32358094; PMCID: PMC9364898.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    149. Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study. J Urol. 2020 10; 204(4):701-706. Liss MA, Newcomb LF, Zheng Y, Garcia MP, Filson CP, Boyer H, Brooks JD, Carroll PR, Cooperberg MR, Ellis WJ, Gleave ME, Martin FM, Morgan T, Nelson PS, Wagner AA, Thompson IM, Lin DW. PMID: 32343189; PMCID: PMC7483329.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    150. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology. 2020 07; 296(1):76-84. Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, Foster BR, Froemming AT, Fütterer JJ, Ganeshan DM, Gertner MR, Mankowski Gettle L, Ghai S, Gupta RT, Hahn ME, Houshyar R, Kim C, Kim CK, Lall C, Margolis DJA, McRae SE, Oto A, Parsons RB, Patel NU, Pinto PA, Polascik TJ, Spilseth B, Starcevich JB, Tammisetti VS, Taneja SS, Turkbey B, Verma S, Ward JF, Warlick CA, Weinberger AR, Yu J, Zagoria RJ, Rosenkrantz AB. PMID: 32315265; PMCID: PMC7373346.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    151. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Prostate. 2020 05; 80(8):653-659. Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP. PMID: 32220141.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    152. Editorial Comment. J Urol. 2020 06; 203(6):1121. Carroll PR, Chu C. PMID: 32186448.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    153. Evaluation of a vaccination training program for pharmacy graduands in Australia. Curr Pharm Teach Learn. 2020 07; 12(7):850-857. Carroll PR, Chen Y, Vicheth P, Webber P, Hanrahan JR. PMID: 32540047.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    154. The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations. Eur Urol. 2020 09; 78(3):335-344. Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 31980309.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    155. Reply by Authors. J Urol. 2020 04; 203(4):733. Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PMID: 31951502.
      View in: PubMed   Mentions:    Fields:    
    156. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol. 2020 03; 214(3):574-578. Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. PMID: 31913068.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    157. Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients. Cancer Med. 2020 01; 9(1):125-132. Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR. PMID: 31714037; PMCID: PMC6943165.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    158. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry. Clin Genitourin Cancer. 2020 02; 18(1):e21-e27. Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS. PMID: 31796344.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    159. Active surveillance for intermediate-risk prostate cancer: yes, but for whom? Curr Opin Urol. 2019 11; 29(6):605-611. Overland MR, Washington SL, Carroll PR, Cooperberg MR, Herlemann A. PMID: 31436567.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    160. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol. 2020 04; 203(4):727-733. Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW. PMID: 31651227; PMCID: PMC7384451.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    161. Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2020 Apr; 203(4):706-712. Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B. PMID: 31642740; PMCID: PMC8274953.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansPHPublic Health
    162. A GABAergic Maf-expressing interneuron subset regulates the speed of locomotion in Drosophila. Nat Commun. 2019 10 22; 10(1):4796. Babski H, Jovanic T, Surel C, Yoshikawa S, Zwart MF, Valmier J, Thomas JB, Enriquez J, Carroll P, Garcès A. PMID: 31641138; PMCID: PMC6805931.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    163. Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts. Cancer. 2020 02 01; 126(3):583-592. Lange JM, Laviana AA, Penson DF, Lin DW, Bill-Axelson A, Carlsson SV, Newcomb LF, Trock BJ, Carter HB, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Etzioni RB. PMID: 31639200; PMCID: PMC6980275.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    164. Reply by Authors. J Urol. 2019 11; 202(5):958. Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC. PMID: 31364932.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    165. SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer. J Urol. 2019 11; 202(5):952-958. Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC. PMID: 31144591.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    166. Hematuria Practice Guidelines That Explicitly Consider Harms and Costs. JAMA Intern Med. 2019 Oct 01; 179(10):1362-1364. Bauer SR, Carroll PR, Grady D. PMID: 31355847; PMCID: PMC6986985.
      View in: PubMed   Mentions:    Fields:    
    167. Germline testing in those at risk of prostate cancer. Can J Urol. 2019 Oct; 26(5 Suppl 2):31-33. Carroll PR, Witte JS, Parsons JK. PMID: 31629425.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    168. Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop. J Urol. 2020 01; 203(1):115-119. Weinstock C, Suzman D, Kluetz P, Baxley J, Viviano C, Ibrahim A, Jarow J, Sridhara R, Liu K, Carroll P, Eggener S, Hu JC, Hussain M, King M, Klein E, Kungel T, Makarov D, Pinto PA, Rini B, Roach M, Sandler H, Schlegel PN, Song D, Goldberg K, Pazdur R, Beaver JA. PMID: 31502940; PMCID: PMC8274949.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    169. A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance. J Urol. 2019 10; 202(4):702-709. Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR. PMID: 31026214.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    170. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer. J Urol. 2019 10; 202(4):689-695. Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM. PMID: 31091175; PMCID: PMC7017721.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    171. Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer. J Urol. 2019 10; 202(4):732-741. Friedlander TW, Welty C, Anantharaman A, Schonhoft JD, Jendrisak A, Lee J, Li P, Hough J, Stromlund A, Edwards M, Sangar S, Kobayashi Y, Simko J, Farrokhian N, Lindquist K, Greene S, Ontiveros P, Graf R, Rodriquez A, Suraneni M, Wang Y, Landers M, Carroll P, Cooperberg MR, Dittamore R, Paris PL. PMID: 31216253.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    172. Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2019 10; 202(4):696-701. Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR. PMID: 30958742.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    173. Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1917-1925. Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM. PMID: 31462398; PMCID: PMC6825577.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    174. Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance. Prostate Cancer Prostatic Dis. 2020 03; 23(1):136-143. Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR. PMID: 31455846; PMCID: PMC8076042.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    175. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts. Eur Urol. 2019 11; 76(5):693-702. Drost FH, Nieboer D, Morgan TM, Carroll PR, Roobol MJ, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP) Consortium. PMID: 31451332.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    176. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. J Urol. 2019 09; 202(3):506-510. Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR. PMID: 30958738.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    177. Guidelines should be assessed based on the underlying evidence. CMAJ. 2019 08 06; 191(31):E871. Carroll PR, Parsons JK. PMID: 31387962; PMCID: PMC6682483.
      View in: PubMed   Mentions:    Fields:    
    178. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry. Eur Urol. 2019 12; 76(6):743-751. Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR. PMID: 31345635.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    179. Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions. Int Braz J Urol. 2019 Jul-Aug; 45(4):713-723. Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR. PMID: 31136112; PMCID: PMC6837611.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    180. Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research. JCO Clin Cancer Inform. 2019 07; 3:1-8. Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL, Herlemann A, Carroll PR, Cooperberg MR. PMID: 31314550; PMCID: PMC6874052.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    181. Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer. J Urol. 2019 07; 202(1):90-95. Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP. PMID: 30810466.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    182. A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study. J Med Internet Res. 2019 06 02; 21(6):e14094. Balakrishnan AS, Nguyen HG, Shinohara K, Au Yeung R, Carroll PR, Odisho AY. PMID: 31199294; PMCID: PMC6592401.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    183. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 01; 5(6):856-863. Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA. PMID: 30920593; PMCID: PMC6567829.
      View in: PubMed   Mentions: 271     Fields:    Translation:HumansCTClinical Trials
    184. Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 2019 Sep; 131:157-165. Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR. PMID: 31150694.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    185. The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement. Eur Urol. 2019 Sep; 76(3):268-272. Cooperberg MR, Carroll PR, Dall'Era MA, Davies BJ, Davis JW, Eggener SE, Feng FY, Lin DW, Morgan TM, Morgans AK, Spratt DE, Taneja SS, Penson DF. PMID: 31128968.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    186. Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer. AJR Am J Roentgenol. 2019 08; 213(2):266-274. Lawhn-Heath C, Flavell RR, Behr SC, Yohannan T, Greene KL, Feng F, Carroll PR, Hope TA. PMID: 31039025.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    187. Editorial Comment. J Urol. 2019 04; 201(4):820. Carroll P, Schmidt B. PMID: 30947462.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    188. Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy. Urology. 2019 07; 129:165-171. Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. PMID: 30928607.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    189. Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems. Am J Mens Health. 2019 Mar-Apr; 13(2):1557988319835326. Tang J, Zhong L, Paoli C, Paciorek A, Carroll P, Wilson L. PMID: 30836832; PMCID: PMC6440060.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    190. The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target. J Natl Cancer Inst. 2019 03 01; 111(3):301-310. Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, Davicioni E, Fong L, Spratt DE, Feng FY. PMID: 30321406.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    191. Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance. J Urol. 2019 02; 201(2):300-307. Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR. PMID: 30179620.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    192. Editorial Comment. J Urol. 2019 02; 201(2):298-299. Carroll P. PMID: 30634361.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    193. Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS). Prostate Cancer Prostatic Dis. 2019 09; 22(3):438-445. Newcomb LF, Zheng Y, Faino AV, Bianchi-Frias D, Cooperberg MR, Brown MD, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Liss M, Morgan TM, Thompson IM, Wagner AA, Carroll PR, Nelson PS, Lin DW. PMID: 30664734; PMCID: PMC6642858.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    194. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. Eur Urol Oncol. 2019 11; 2(6):685-690. Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY. PMID: 31411984.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    195. Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer. Eur Urol. 2019 06; 75(6):950-958. Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM. PMID: 30638635.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    196. Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS. J Urol. 2019 01; 201(1):106-111. Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW. PMID: 30076904; PMCID: PMC10958899.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    197. Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer. Urology. 2019 03; 125:154-162. Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. PMID: 30580002.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    198. Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology. J Nucl Med. 2019 06; 60(6):786-793. Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR. PMID: 30530831; PMCID: PMC6581235.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    199. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. J Nucl Med. 2019 07; 60(7):910-916. Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. PMID: 30464040; PMCID: PMC6604687.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    200. Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Nov 15; 7(11):e11257. Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM. PMID: 30442638; PMCID: PMC6265599.
      View in: PubMed   Mentions: 6  
    201. Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 2018 12; 289(3):730-737. Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. PMID: 30226456; PMCID: PMC6283324.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    202. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy. Eur Urol. 2018 12; 74(6):731-738. McKiernan J, Donovan MJ, Margolis E, Partin A, Carter B, Brown G, Torkler P, Noerholm M, Skog J, Shore N, Andriole G, Thompson I, Carroll P. PMID: 30237023.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCellsCTClinical Trials
    203. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies. Eur Urol Oncol. 2019 05; 2(3):333-336. van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, Hyndman E, Moore CM, Gnanapragasam V, Van Hemelrijck M, Dasgupta P, Bangma C, Roobol M, Villers A, Rannikko A, Valdagni R, Perry A, Hugosson J, Rubio-Briones J, Bjartell A, Hefermehl L, Shiong LL, Frydenberg M, Kakehi Y, Chung BH, van der Kwast T, Obbink H, van der Linden W, Hulsen T, de Jonge C, Kattan M, Xinge J, Muir K, Lophatananon A, Fahey M, Steyerberg E, Nieboer D, Zhang L, Guo W, Benfante N, Cowan J, Patil D, Tolosa E, Kim TK, Mamedov A, LaPointe V, Crump T, Kimberly-Duffell J, Santaolalla A, Nieboer D, Olivier JT, Rancati T, Ahlgren H, Mascarós J, Löfgren A, Lehmann K, Lin CH, Hirama H, Lee KS, Jenster G, Auvinen A, Bjartell A, Haider M, van Bochove K, Carter B, Gledhill S, Buzza M, Bangma C, Roobol M, Bruinsma S, Helleman J. PMID: 31200849.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    204. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy. Eur Urol. 2018 11; 74(5):668-675. Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR. PMID: 30181067.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    205. Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis. 2019 03; 22(1):117-124. Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR. PMID: 30171230.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    206. USPTF Prostate Cancer Screening Recommendations-A Step in the Right Direction. JAMA Surg. 2018 08 01; 153(8):701-702. Carroll PR. PMID: 29801146.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    207. Effect of Oscillation on Perineal Pressure in Cyclists: Implications for Micro-Trauma. Sex Med. 2018 Sep; 6(3):239-247. Sanford T, Gadzinski AJ, Gaither T, Osterberg EC, Murphy GP, Carroll PR, Breyer BN. PMID: 29936216; PMCID: PMC6085221.
      View in: PubMed   Mentions: 3  
    208. The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer. Eur Urol. 2018 10; 74(4):444-452. Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E, Carroll PR. PMID: 29853306; PMCID: PMC6586429.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    209. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018 10; 1(5):386-394. Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 31158077.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    210. Optimal Radical Therapy for Localized Prostate Cancer: Recreation of the Self-Fulfilling Prophecy With Combination Brachytherapy? J Clin Oncol. 2018 10 10; 36(29):2914-2917. Spratt DE, Carroll PR. PMID: 29782208.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    211. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer. Eur Urol Oncol. 2018 05; 1(1):78-82. Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T. PMID: 31100231.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    212. Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med. 2018 05 02; 10(439). Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D. PMID: 29720449; PMCID: PMC6045425.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansAnimalsCells
    213. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol. 2018 05; 73(5):706-712. Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Lin DW. PMID: 29433973; PMCID: PMC6064187.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    214. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes. Eur Urol. 2018 08; 74(2):211-217. Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Zheng Y. PMID: 29433975; PMCID: PMC6263168.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    215. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer. Oncotarget. 2018 Jan 19; 9(5):6550-6561. Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, Feng Z, Brooks JD. PMID: 29464091; PMCID: PMC5814231.
      View in: PubMed   Mentions: 7     Fields:    
    216. Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction. Mol Imaging. 2018 Jan-Dec; 17:1536012118811741. Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, Hope TA. PMID: 31749411; PMCID: PMC6287320.
      View in: PubMed   Mentions: 3     Fields:    
    217. Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy. JAMA Oncol. 2017 12 01; 3(12):1663-1672. Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, Jenkins RB, Davicioni E, Ross AE, Schaeffer EM, Nguyen PL, Carroll PR, Karnes RJ, Spratt DE, Feng FY. PMID: 28494073; PMCID: PMC5824281.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    218. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. J Clin Oncol. 2018 02 20; 36(6):581-590. Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL. PMID: 29185869; PMCID: PMC6530900.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    219. Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts. Ann Intern Med. 2018 01 02; 168(1):1-9. Inoue LYT, Lin DW, Newcomb LF, Leonardson AS, Ankerst D, Gulati R, Carter HB, Trock BJ, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Mamedov A, Penson DF, Etzioni R. PMID: 29181514; PMCID: PMC5752581.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    220. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate. 2018 Jan; 78(1):32-39. Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM. PMID: 29105845; PMCID: PMC5716878.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    221. Cycling, and Male Sexual and Urinary Function: Results from a Large, Multinational, Cross-Sectional Study. J Urol. 2018 03; 199(3):798-804. Awad MA, Gaither TW, Murphy GP, Chumnarnsongkhroh T, Metzler I, Sanford T, Sutcliffe S, Eisenberg ML, Carroll PR, Osterberg EC, Breyer BN. PMID: 29031767.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    222. Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa). PLoS One. 2017; 12(10):e0185535. Leapman MS, Westphalen AC, Ameli N, Lawrence HJ, Febbo PG, Cooperberg MR, Carroll PR. PMID: 29016610; PMCID: PMC5634556.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    223. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers. Prostate. 2017 Dec; 77(16):1573-1582. Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhenn IA, Levine PH, Hsing AW, Cook MB. PMID: 28971497; PMCID: PMC5683095.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    224. Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard. NMR Biomed. 2017 Dec; 30(12). Starobinets O, Simko JP, Kuchinsky K, Kornak J, Carroll PR, Greene KL, Kurhanewicz J, Noworolski SM. PMID: 28961382; PMCID: PMC9592076.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    225. Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol. 2018 03; 199(3):699-705. Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. PMID: 28941918.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    226. Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy. J Urol. 2018 03; 199(3):719-725. Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL. PMID: 28941923.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    227. Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer. EJNMMI Res. 2017 Sep 19; 7(1):77. Lake ST, Greene KL, Westphalen AC, Behr SC, Zagoria R, Small EJ, Carroll PR, Hope TA. PMID: 28929350; PMCID: PMC5605480.
      View in: PubMed   Mentions: 17  
    228. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy. Cancer. 2017 Dec 01; 123(23):4574-4582. Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP. PMID: 28881475.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    229. Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer. Radiol Bras. 2017 Sep-Oct; 50(5):299-307. Leapman MS, Wang ZJ, Behr SC, Kurhanewicz J, Zagoria RJ, Carroll PR, Westphalen AC. PMID: 29085163; PMCID: PMC5656070.
      View in: PubMed   Mentions: 5  
    230. Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations. Cancer Epidemiol Biomarkers Prev. 2017 11; 26(11):1660-1666. Cook MB, Stanczyk FZ, Wood SN, Pfeiffer RM, Hafi M, Veneroso CC, Lynch B, Falk RT, Zhou CK, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhann IA, Levine PH, Hsing AW. PMID: 28830872; PMCID: PMC5668163.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    231. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital. Urol Oncol. 2017 11; 35(11):663.e9-663.e14. Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN. PMID: 28826701.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    232. Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2017 12; 58(12):1956-1961. Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR. PMID: 28522741.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    233. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy. Eur Urol. 2018 02; 73(2):215-223. Herlemann A, Cowan JE, Carroll PR, Cooperberg MR. PMID: 28499617.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    234. AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer. J Urol. 2017 10; 198(4):832-838. Fulgham PF, Rukstalis DB, Turkbey IB, Rubenstein JN, Taneja S, Carroll PR, Pinto PA, Bjurlin MA, Eggener S. PMID: 28483574; PMCID: PMC7905434.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    235. Management of intermediate-risk prostate cancer with active surveillance: never or sometimes? Curr Opin Urol. 2017 May; 27(3):231-237. Masic S, Washington SL, Carroll PR. PMID: 28234748.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    236. The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study. JMIR Cancer. 2017 Apr 18; 3(1):e5. Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM. PMID: 28420602; PMCID: PMC5413797.
      View in: PubMed   Mentions: 16  
    237. Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting. Prostate Int. 2017 Sep; 5(3):95-103. Kim CS, Lee JY, Chung BH, Kim WJ, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Wu TL, Lojanapiwat B, Türkeri L, Murphy DG, Gardiner RA, Moretti K, Cooperberg M, Carroll P, Mun SK, Hinotsu S, Hirao Y, Ozono S, Horie S, Onozawa M, Kitagawa Y, Kitamura T, Namiki M, Akaza H. PMID: 28828352; PMCID: PMC5551923.
      View in: PubMed   Mentions: 3  
    238. Active Surveillance in Younger Men With Prostate Cancer. J Clin Oncol. 2017 Jun 10; 35(17):1898-1904. Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR. PMID: 28346806; PMCID: PMC5466007.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    239. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments. J Urol. 2017 09; 198(3):671-677. Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR. PMID: 28342935; PMCID: PMC5636214.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    240. Low-risk Prostate Cancer: Identification, Management, and Outcomes. Eur Urol. 2017 08; 72(2):238-249. Moschini M, Carroll PR, Eggener SE, Epstein JI, Graefen M, Montironi R, Parker C. PMID: 28318726.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    241. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure. Nat Rev Urol. 2017 May; 14(5):312-322. Bruinsma SM, Roobol MJ, Carroll PR, Klotz L, Pickles T, Moore CM, Gnanapragasam VJ, Villers A, Rannikko A, Valdagni R, Frydenberg M, Kakehi Y, Filson CP, Bangma CH, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. PMID: 28290462.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    242. A randomised clinical study to determine the effect of a toothpaste containing enzymes and proteins on plaque oral microbiome ecology. Sci Rep. 2017 02 27; 7:43344. Adams SE, Arnold D, Murphy B, Carroll P, Green AK, Smith AM, Marsh PD, Chen T, Marriott RE, Brading MG. PMID: 28240240; PMCID: PMC5327414.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    243. Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards. Br J Clin Pharmacol. 2017 06; 83(6):1185-1196. Chan B, Reeve E, Matthews S, Carroll PR, Long JC, Held F, Latt M, Naganathan V, Caplan GA, Hilmer SN. PMID: 28009444; PMCID: PMC5427233.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    244. Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes. Eur Urol. 2017 05; 71(5):750-759. Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR. PMID: 27940155.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    245. Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate. 2017 03; 77(4):425-434. Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP. PMID: 27900799; PMCID: PMC5479703.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    246. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study. Eur Urol. 2017 09; 72(3):448-454. Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll PR, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Canary Prostate Active Surveillance Study Investigators. PMID: 27889277; PMCID: PMC7327706.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    247. MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study. PLoS One. 2016; 11(11):e0165236. Eminaga O, Wei W, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L, Brooks JD. PMID: 27846218; PMCID: PMC5112958.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    248. Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol. 2017 04; 197(4):1026-1033. Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Lin DW. PMID: 27810448; PMCID: PMC5571762.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    249. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort. Am J Surg Pathol. 2016 11; 40(11):1439-1456. McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, Lance RS, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. PMID: 27635949.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    250. Risk Stratification of Newly Diagnosed Prostate Cancer with Genomic Platforms. Urol Pract. 2017 Jul; 4(4):322-328. Leapman MS, Carroll PR. PMID: 37592678.
      View in: PubMed   Mentions:    Fields:    
    251. Variation and Predictors of Surgical Case Costs among Urologists. Urol Pract. 2017 Jul; 4(4):277-284. Hampson LA, Odisho AY, Meng MV, Carroll PR. PMID: 30906821; PMCID: PMC6425944.
      View in: PubMed   Mentions: 1     Fields:    
    252. What is the best way not to treat prostate cancer? Urol Oncol. 2017 02; 35(2):42-50. Leapman MS, Carroll PR. PMID: 27746147.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    253. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. Lancet Oncol. 2016 Nov; 17(11):1612-1620. Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB, Nguyen PL, Feng FY. PMID: 27743920.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    254. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force. Eur Urol. 2017 02; 71(2):274-280. Villa S, Kendel F, Venderbos L, Rancati T, Bangma C, Carroll P, Denis L, Klotz L, Korfage IJ, Lane AJ, Magnani T, Mastris K, Rannikko A, Roobol M, Trock B, Van den Bergh R, Van Poppel H, Valdagni R, Bellardita L. PMID: 27720532.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    255. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One. 2016; 11(10):e0164558. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. PMID: 27711167; PMCID: PMC5053526.
      View in: PubMed   Mentions:    Fields:    
    256. Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunol Res. 2016 11; 4(11):948-958. Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L. PMID: 27688020; PMCID: PMC5115633.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    257. A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy. J Urol. 2017 02; 197(2):369-375. Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR. PMID: 27693447.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    258. 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience. J Nucl Med. 2017 Jan; 58(1):81-84. Hope TA, Truillet C, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, Carroll PR, Small EJ, Evans MJ. PMID: 27660139; PMCID: PMC5209643.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansAnimalsCells
    259. A complicated case of splenic injury after colonoscopy - a video vignette. Colorectal Dis. 2016 Sep; 18(9):920-1. Kelly B, Heneghan H, Carroll P, McDermott E. PMID: 27454078.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    260. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Eur Urol. 2017 08; 72(2):275-281. Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR. PMID: 27595378.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    261. 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2017 Feb; 282(2):429-436. Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. PMID: 27513849; PMCID: PMC5283870.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    262. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2017 02; 15(1):93-99. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. PMID: 27522449.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    263. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 Oct; 96:116-120. Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, Klein EA. PMID: 27450937; PMCID: PMC5568096.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    264. A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment. Prostate Cancer Prostatic Dis. 2016 12; 19(4):390-394. Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll PR, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, Lin DW, Thompson IM. PMID: 27431498; PMCID: PMC5564326.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    265. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. JAMA Oncol. 2016 Jul 01; 2(7):882-9. McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM, Carroll P. PMID: 27032035.
      View in: PubMed   Mentions: 294     Fields:    Translation:HumansCells
    266. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. J Urol. 2016 11; 196(5):1408-1414. Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR. PMID: 27352635; PMCID: PMC5542578.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    267. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. Eur Urol. 2017 04; 71(4):648-655. Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, Carroll P, Haider M, Kasivisvanathan V, Kirkham A, Klotz L, Ouzzane A, Padhani AR, Panebianco V, Pinto P, Puech P, Rannikko A, Renard-Penna R, Touijer K, Turkbey B, van Poppel H, Valdagni R, Walz J, Schoots I. PMID: 27349615.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    268. Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort. Prostate. 2016 11; 76(15):1409-19. Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L. PMID: 27325561; PMCID: PMC5557496.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    269. PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer. Eur Urol Focus. 2016 Jun; 2(2):180-188. Lotan TL, Wei W, Morais CL, Hawley ST, Fazli L, Hurtado-Coll A, Troyer D, McKenney JK, Simko J, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. PMID: 27617307; PMCID: PMC5014432.
      View in: PubMed   Mentions: 36     Fields:    
    270. Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. Mod Pathol. 2016 08; 29(8):904-14. Lotan TL, Wei W, Ludkovski O, Morais CL, Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L, Hurtado-Coll A, McKenney JK, Simko J, Carroll PR, Gleave M, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Lance R, Troyer D, Squire JA. PMID: 27174589; PMCID: PMC4967011.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    271. Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance. Eur Urol. 2017 09; 72(3):329-332. Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR. PMID: 27157998.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    272. Immediate androgen deprivation: for all or for some? Lancet Oncol. 2016 06; 17(6):683-684. Leapman MS, Carroll PR. PMID: 27155739.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    273. Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies. Prostate Cancer Prostatic Dis. 2016 09; 19(3):264-70. Tretiakova MS, Wei W, Boyer HD, Newcomb LF, Hawley S, Auman H, Vakar-Lopez F, McKenney JK, Fazli L, Simko J, Troyer DA, Hurtado-Coll A, Thompson IM, Carroll PR, Ellis WJ, Gleave ME, Nelson PS, Lin DW, True LD, Feng Z, Brooks JD. PMID: 27136741; PMCID: PMC5536893.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    274. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. J Natl Compr Canc Netw. 2016 May; 14(5):509-19. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Moses KA, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenkle P, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA. PMID: 27160230; PMCID: PMC10184498.
      View in: PubMed   Mentions: 150     Fields:    Translation:Humans
    275. Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance. J Urol. 2016 Sep; 196(3):727-33. Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll PR. PMID: 27117443.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    276. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery. Am J Clin Oncol. 2016 Apr; 39(2):167-72. Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M. PMID: 24441584.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    277. Asia prostate cancer study (A-CaP Study) launch symposium. Prostate Int. 2016 Sep; 4(3):88-96. Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong TA, Lojanapiwat B, Wu TL, Kim WJ, Murphy D, Ogawa O, Carroll P, Naito S, Tsukamoto T. PMID: 27689065; PMCID: PMC5031897.
      View in: PubMed   Mentions: 6  
    278. Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens. J Mol Diagn. 2016 05; 18(3):395-406. Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP. PMID: 26945428; PMCID: PMC4851733.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    279. Active surveillance for prostate cancer: a narrative review of clinical guidelines. Nat Rev Urol. 2016 Mar; 13(3):151-67. Bruinsma SM, Bangma CH, Carroll PR, Leapman MS, Rannikko A, Petrides N, Weerakoon M, Bokhorst LP, Roobol MJ, Movember GAP3 consortium. PMID: 26813955.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    280. Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score. Urology. 2016 Mar; 89:69-75. Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ. PMID: 26723180.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    281. NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw. 2015 Dec; 13(12):1534-61. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D. PMID: 26656522.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansPHPublic Health
    282. Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015 Nov 27; 13:288. Carlsson S, Leapman M, Carroll P, Schröder F, Albertsen PC, Ilic D, Barry M, Frosch DL, Vickers A. PMID: 26612204; PMCID: PMC4662021.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    283. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL. PMID: 26585352; PMCID: PMC5493324.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    284. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Sci Signal. 2015 Nov 17; 8(403):ra116. Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D. PMID: 26577921; PMCID: PMC4739654.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    285. Treatment Trends for Prostate Cancer--Reply. JAMA. 2015 Nov 10; 314(18):1977-8. Cooperberg MR, Carroll PR. PMID: 26547474.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    286. New Genetic Markers for Prostate Cancer. Urol Clin North Am. 2016 Feb; 43(1):7-15. Leapman MS, Carroll PR. PMID: 26614025.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    287. Bicycle Trauma Injuries and Hospital Admissions in the United States, 1998-2013. JAMA. 2015 Sep 01; 314(9):947-9. Sanford T, McCulloch CE, Callcut RA, Carroll PR, Breyer BN. PMID: 26325564; PMCID: PMC4896174.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    288. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. J Urol. 2016 Feb; 195(2):313-20. Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, Nicolas MM, Sanda MG, Simko J, So A, Tretiakova MS, Troyer DA, True LD, Vakar-Lopez F, Virgin J, Wagner AA, Wei JT, Zheng Y, Nelson PS, Lin DW, Canary PASS Investigators. PMID: 26327354; PMCID: PMC4970462.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansPHPublic Health
    289. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. PLoS One. 2015; 10(7):e0132343. Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, McKenney JK. PMID: 26172920; PMCID: PMC4501723.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    290. Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. JAMA. 2015 Jul 07; 314(1):80-2. Cooperberg MR, Carroll PR. PMID: 26151271.
      View in: PubMed   Mentions: 259     Fields:    Translation:Humans
    291. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. Eur Urol. 2015 Sep; 68(3):458-63. Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 26138041.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    292. What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer? J Urol. 2015 Sep; 194(3):615-6. Dall'Era M, Carroll P. PMID: 26079332.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    293. A comparison of medical and pharmacy students' knowledge and skills of pharmacology and pharmacotherapy. Br J Clin Pharmacol. 2015 Jun; 79(6):1028-9. Hilmer SN, Seale JP, Carroll PR. PMID: 25425109; PMCID: PMC4456135.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    294. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter? BJU Int. 2015 Nov; 116(5):713-20. Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll PR. PMID: 25600860.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    295. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR. PMID: 25983194.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    296. Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer. BJU Int. 2016 Jan; 117(1):102-9. Cooperberg MR, Hinotsu S, Namiki M, Carroll PR, Akaza H. PMID: 25238114.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    297. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. Prostate. 2015 Aug 01; 75(11):1206-15. Troyer DA, Jamaspishvili T, Wei W, Feng Z, Good J, Hawley S, Fazli L, McKenney JK, Simko J, Hurtado-Coll A, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Squire JA. PMID: 25939393; PMCID: PMC4475421.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    298. Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. Eur Urol. 2015 Dec; 68(6):1083-8. Ankerst DP, Xia J, Thompson IM, Hoefler J, Newcomb LF, Brooks JD, Carroll PR, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW. PMID: 25819722; PMCID: PMC4583313.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    299. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Eur J Cancer. 2015 May; 51(7):817-24. Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA. PMID: 25794605; PMCID: PMC4402138.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    300. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer. Eur Urol. 2015 Sep; 68(3):480-6. Hampson LA, Cowan JE, Zhao S, Carroll PR, Cooperberg MR. PMID: 25656807.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    301. Current Use of Imaging after Primary Treatment of Prostate Cancer. J Urol. 2015 Jul; 194(1):98-104. Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR. PMID: 25640648.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    302. Mycobacterium tuberculosis H37Rv has a single nucleotide polymorphism in PhoR which affects cell wall hydrophobicity and gene expression. Microbiology (Reading). 2015 Apr; 161(Pt 4):765-773. Schreuder LJ, Carroll P, Muwanguzi-Karugaba J, Kokoczka R, Brown AC, Parish T. PMID: 25635271.
      View in: PubMed   Mentions: 8     Fields:    Translation:Cells
    303. Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes. J Urol. 2015 Jul; 194(1):85-90. Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll PR. PMID: 25623742.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    304. Active surveillance for low-risk prostate cancer: developments to date. Eur Urol. 2015 Apr; 67(4):646-8. Bangma CH, Valdagni R, Carroll PR, van Poppel H, Klotz L, Hugosson J. PMID: 25435266.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    305. Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test. Value Health. 2014 Nov; 17(7):A651. Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P. PMID: 27202352.
      View in: PubMed   Mentions:    Fields:    
    306. Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics. Clin Cancer Res. 2014 Oct 15; 20(20):5302-10. Xia J, Trock BJ, Gulati R, Mallinger L, Cooperberg MR, Carroll PR, Carter HB, Etzioni R. PMID: 25320374; PMCID: PMC4203422.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    307. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2015 Jan; 75(1):60-9. Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan JM. PMID: 25284284; PMCID: PMC4257852.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    308. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR. PMID: 25261803.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    309. Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer. J Natl Cancer Inst. 2014 Nov; 106(11). Fong L, Carroll P, Weinberg V, Chan S, Lewis J, Corman J, Amling CL, Stephenson RA, Simko J, Sheikh NA, Sims RB, Frohlich MW, Small EJ. PMID: 25255802; PMCID: PMC4241888.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCellsCTClinical Trials
    310. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015 Oct; 68(4):600-8. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. PMID: 25242555.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    311. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Sep; 12(9):1211-9; quiz 1219. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M, National comprehensive cancer network. PMID: 25190691.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    312. Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60. Eur Urol. 2014 Dec; 66(6):e117-8. Klein EA, Cooperberg MR, Carroll PR. PMID: 25150174.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    313. Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management. Prostate Int. 2014; 2(2):50-69. Akaza H, Kim CS, Carroll P, Choi IY, Chung BH, Cooperberg MR, Hirao Y, Hinotsu S, Horie S, Lee JY, Namiki M, Ng CF, Onozawa M, Ozono S, Ueno S, Umbas R, Ye D, Zhu G. PMID: 26153555; PMCID: PMC4099396.
      View in: PubMed   Mentions: 3  
    314. miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance. PLoS One. 2014; 9(6):e98597. Wang SY, Shiboski S, Belair CD, Cooperberg MR, Simko JP, Stoppler H, Cowan J, Carroll PR, Blelloch R. PMID: 24893170; PMCID: PMC4043973.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    315. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014 Sep; 66(3):550-60. Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR. PMID: 24836057.
      View in: PubMed   Mentions: 277     Fields:    Translation:HumansCells
    316. Updated trends in imaging use in men diagnosed with prostate cancer. Prostate Cancer Prostatic Dis. 2014 Sep; 17(3):246-51. Porten SP, Smith A, Odisho AY, Litwin MS, Saigal CS, Carroll PR, Cooperberg MR, Urologic Disease of America Project. PMID: 24819235; PMCID: PMC4266691.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    317. Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? J Natl Compr Canc Netw. 2014 May; 12(5 Suppl):768-71. Carroll PR, Vickers AJ. PMID: 24853213.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    318. Evolution and immediate future of US screening guidelines. Urol Clin North Am. 2014 May; 41(2):229-35. Greene KL, Punnen S, Carroll PR. PMID: 24725485.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    319. Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer. Curr Opin Urol. 2014 May; 24(3):288-92. Welty CJ, Cooperberg MR, Carroll PR. PMID: 24614347; PMCID: PMC6586410.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    320. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. Eur Urol. 2015 Mar; 67(3):451-7. Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR. PMID: 24746973.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    321. Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. Urology. 2014 May; 83(5):975-8. Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA. PMID: 24661332.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    322. A risk-adjusted definition of biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Jun; 17(2):174-9. Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll PR, Lin DW. PMID: 24614692.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    323. Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes. PLoS One. 2014; 9(3):e89754. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. PMID: 24594774; PMCID: PMC3940667.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    324. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging. 2014 Mar; 31(3):225-32. Bennett A, Gnjidic D, Gillett M, Carroll P, Matthews S, Johnell K, Fastbom J, Hilmer S. PMID: 24452921.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    325. A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology. 2014 Mar; 83(3):592-6. Vickers AJ, Thompson IM, Klein E, Carroll PR, Scardino PT. PMID: 24581521.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    326. The ongoing need for improved risk stratification and monitoring for those on active surveillance for early stage prostate cancer. Eur Urol. 2014 Jun; 65(6):1032-3. Welty CJ, Carroll PR. PMID: 24636678.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    327. Age and baseline quality of life at radical prostatectomy--who has the most to lose? J Urol. 2014 Aug; 192(2):396-401. Brajtbord JS, Punnen S, Cowan JE, Welty CJ, Carroll PR. PMID: 24582539.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    328. Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer. BJU Int. 2014 Dec; 114(6b):E18-E24. Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR. PMID: 24712895.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    329. The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration. Eur J Clin Pharmacol. 2014 May; 70(5):549-55. Johnston C, Hilmer SN, McLachlan AJ, Matthews ST, Carroll PR, Kirkpatrick CM. PMID: 24522409.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    330. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 24504435; PMCID: PMC3990413.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    331. Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology. Radiother Oncol. 2014 Feb; 110(2):303-8. Anwar M, Westphalen AC, Jung AJ, Noworolski SM, Simko JP, Kurhanewicz J, Roach M, Carroll PR, Coakley FV. PMID: 24444524; PMCID: PMC3969841.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    332. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014 Jun; 65(6):1046-55. Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. PMID: 24439788; PMCID: PMC4113338.
      View in: PubMed   Mentions: 382     Fields:    Translation:Humans
    333. The argument for palliative care in prostate cancer. Transl Androl Urol. 2013 Dec; 2(4):278-80. Sanford MT, Greene KL, Carroll PR. PMID: 26816740; PMCID: PMC4708113.
      View in: PubMed   Mentions: 2  
    334. Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort. Urology. 2014 Jan; 83(1):33-8. Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR. PMID: 24246319.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    335. Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. J Magn Reson Imaging. 2014 Aug; 40(2):314-23. Jung AJ, Westphalen AC, Kurhanewicz J, Wang ZJ, Carroll PR, Simko JP, Coakley FV. PMID: 24924999; PMCID: PMC4059791.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    336. Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry. J Urol. 2014 Apr; 191(4):964-70. Cary KC, Singla N, Cowan JE, Carroll PR, Cooperberg MR. PMID: 24184370.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    337. Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registry. Cancer. 2014 Feb 15; 120(4):507-12. Cary KC, Paciorek A, Fuldeore MJ, Carroll PR, Cooperberg MR. PMID: 24496867.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    338. Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates. J Magn Reson Imaging. 2014 May; 39(5):1223-9. Starobinets O, Guo R, Simko JP, Kuchinsky K, Kurhanewicz J, Carroll PR, Greene KL, Noworolski SM. PMID: 24136783; PMCID: PMC3984354.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    339. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014 Apr; 191(4):971-6. Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan JM. PMID: 24095905; PMCID: PMC5480381.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    340. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013 Oct; 14(11):1112-1120. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJM, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH. PMID: 24051140.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    341. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR. PMID: 24035632.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    342. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2013 Dec; 73(16):1786-95. Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan JM. PMID: 24038157; PMCID: PMC5501162.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    343. Early salvage radiotherapy following radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1034-43. Pfister D, Bolla M, Briganti A, Carroll P, Cozzarini C, Joniau S, van Poppel H, Roach M, Stephenson A, Wiegel T, Zelefsky MJ. PMID: 23972524.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    344. Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomy. J Robot Surg. 2014 Jun; 8(2):99-104. Punnen S, Clint Cary K, Glass AS, Cowan JE, Carroll PR. PMID: 27637518.
      View in: PubMed   Mentions: 3     Fields:    
    345. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014 Mar; 23(2):495-508. Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C. PMID: 23943258.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    346. Reply to A. Azad et al. J Clin Oncol. 2013 Sep 10; 31(26):3296-7. Cooperberg MR, Cowan JE, Carroll PR. PMID: 23943835.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    347. Editorial comment. J Urol. 2013 Oct; 190(4):1223. Cary KC, Carroll PR. PMID: 23856519.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    348. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU Int. 2013 Jul; 112(2):E67-75. Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR. PMID: 23795800.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    349. Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes. Jpn J Clin Oncol. 2013 Jul; 43(7):756-66. Akaza H, Hinotsu S, Cooperberg MR, Chung BH, Youl Lee J, Umbas R, Tsukamoto T, Namiki M, Carroll P. PMID: 23723314.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    350. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era. Urology. 2013 Jul; 82(1):60-5. Glass AS, Cowan JE, Fuldeore MJ, Cooperberg MR, Carroll PR, Kenfield SA, Greene KL. PMID: 23706257.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    351. Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy. J Magn Reson Imaging. 2014 Mar; 39(3):519-25. Chang ST, Westphalen AC, Jha P, Jung AJ, Carroll PR, Kurhanewicz J, Coakley FV. PMID: 23681669; PMCID: PMC3748229.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    352. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. Eur Urol. 2014 Jun; 65(6):1171-7. Punnen S, Freedland SJ, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR. PMID: 23587869.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    353. Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology. 2013 Jul; 82(1):154-9. Odisho AY, Washington SL, Meng MV, Cowan JE, Simko JP, Carroll PR. PMID: 23522995; PMCID: PMC3696410.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    354. Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res. 2013 May 01; 19(9):2442-50. Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll PR, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS, Canary Prostate Active Surveillance Study Investigators. PMID: 23515404; PMCID: PMC3674574.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    355. How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer? BJU Int. 2013 Aug; 112(4):E314-20. Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR. PMID: 23451984.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    356. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol. 2013 Apr 10; 31(11):1428-34. Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, Gutin A, Lanchbury JS, Swanson GP, Stone S, Carroll PR. PMID: 23460710.
      View in: PubMed   Mentions: 152     Fields:    Translation:Humans
    357. Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy. J Urol. 2013 Sep; 190(3):981-6. Harris CR, Punnen S, Carroll PR. PMID: 23410984.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    358. Active surveillance: does serial prostate biopsy increase histological inflammation? Prostate Cancer Prostatic Dis. 2013 Jun; 16(2):165-9. Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll PR. PMID: 23318528.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    359. Focal therapy: a new active surveillance tool? Oncology (Williston Park). 2013 Jan 15; 27(1). Glass AS, Carroll PR. PMID: 25188237.
      View in: PubMed   Mentions:    Fields:    
    360. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Adv Anat Pathol. 2013 Jan; 20(1):39-44. Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, Carroll PR, Chan JM, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, Feng Z, True LD, Brooks JD. PMID: 23232570; PMCID: PMC3535290.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    361. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013 Jan; 189(1 Suppl):S2-S11. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P, American Urological Association. PMID: 23234625.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    362. Role of active surveillance in the management of localized prostate cancer. J Natl Cancer Inst Monogr. 2012 Dec; 2012(45):202-6. Glass AS, Cooperberg MR, Meng MV, Carroll PR. PMID: 23271774; PMCID: PMC3540869.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    363. Salvage therapies after radiation therapy. Urol Oncol. 2012 Nov-Dec; 30(6):940-1. Eastham JA, Carroll P, Pisters L, Nguyen PT, Touijer K. PMID: 23218071.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    364. Prostate cancer mortality following active surveillance versus immediate radical prostatectomy. Clin Cancer Res. 2012 Oct 01; 18(19):5471-8. Xia J, Trock BJ, Cooperberg MR, Gulati R, Zeliadt SB, Gore JL, Lin DW, Carroll PR, Carter HB, Etzioni R. PMID: 23008476; PMCID: PMC3604990.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    365. Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int. 2013 Feb; 111(2):213-20. Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF. PMID: 22928860; PMCID: PMC3540193.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    366. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol. 2012 Oct 01; 30(28):3540-4. Choe KS, Cowan JE, Chan JM, Carroll PR, D'Amico AV, Liauw SL. PMID: 22927523; PMCID: PMC3454771.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    367. Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019. Eur Urol. 2012 Nov; 62(5):e88. Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR. PMID: 22921716.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    368. The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. J Urol. 2012 Oct; 188(4):1252-8. Hilton JF, Blaschko SD, Whitson JM, Cowan JE, Carroll PR. PMID: 22902015.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    369. Gender differences in academic productivity and academic career choice among urology residents. J Urol. 2012 Oct; 188(4):1286-90. Yang G, Villalta JD, Weiss DA, Carroll PR, Breyer BN. PMID: 22902027; PMCID: PMC3552430.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    370. Active surveillance for low-risk prostate cancer. Crit Rev Oncol Hematol. 2013 Mar; 85(3):295-302. Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, Kakehi Y, Lane JA, Schröder FH, Semjonow A, Trock BJ, Valdagni R. PMID: 22878262.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    371. The effect of behavioural risk factors on osteoporosis in Irish women. Ir J Med Sci. 2013 Mar; 182(1):97-105. Cummins NM, Jakeman PM, Sestak I, Murphy N, Carroll P. PMID: 22843417.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    372. Early detection of prostate cancer: more information, more clarity. Eur Urol. 2012 Nov; 62(5):753-5; discussion 755-6. Glass AS, Cooperberg MR, Carroll PR. PMID: 22766168.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    373. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram. Prostate Cancer Prostatic Dis. 2012 Dec; 15(4):374-9. Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA. PMID: 22710832; PMCID: PMC3815610.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    374. Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clin Imaging. 2012 Sep-Oct; 36(5):547-52. Jung AJ, Coakley FV, Shinohara K, Carroll PR, Kurhanewicz J, Cowan JE, Westphalen AC. PMID: 22920360; PMCID: PMC3694423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    375. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012 Dec; 62(6):976-83. Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS. PMID: 22698574.
      View in: PubMed   Mentions: 209     Fields:    Translation:Humans
    376. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol. 2012 Sep; 62(3):368-81. Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carroll PR, Costello A, Eastham JA, Ficarra V, Guazzoni G, Menon M, Novara G, Patel VR, Stolzenburg JU, Van der Poel H, Van Poppel H, Mottrie A, Pasadena Consensus Panel. PMID: 22763081.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    377. The quantitative Gleason score improves prostate cancer risk assessment. Cancer. 2012 Dec 15; 118(24):6046-54. Reese AC, Cowan JE, Brajtbord JS, Harris CR, Carroll PR, Cooperberg MR. PMID: 22674220.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    378. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep; 62(3):382-404. Novara G, Ficarra V, Mocellin S, Ahlering TE, Carroll PR, Graefen M, Guazzoni G, Menon M, Patel VR, Shariat SF, Tewari AK, Van Poppel H, Zattoni F, Montorsi F, Mottrie A, Rosen RC, Wilson TG. PMID: 22749851.
      View in: PubMed   Mentions: 145     Fields:    Translation:Humans
    379. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012 Sep; 62(3):405-17. Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, Van der Poel H, Wilson TG, Zattoni F, Mottrie A. PMID: 22749852.
      View in: PubMed   Mentions: 382     Fields:    Translation:Humans
    380. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. PMID: 22553345.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    381. Characteristics of older and younger patients with suspected paracetamol toxicity. Australas J Ageing. 2012 Sep; 31(3):190-3. Kane A, Mitchell SJ, Carroll PR, Matthews S, Hilmer SN. PMID: 22950592.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    382. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology. Eur Urol. 2013 May; 63(5):936-40. Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR. PMID: 22521093; PMCID: PMC3443544.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    383. Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109. Urology. 2012 Mar; 79(3):633-7. Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White R, Hemstreet GP, Crawford ED, Thompson IM, Klein EA. PMID: 22386416; PMCID: PMC3839235.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    384. Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come. Arch Intern Med. 2012 Feb 13; 172(3):280-3. Aaronson DS, Odisho AY, Hills N, Cress R, Carroll PR, Dudley RA, Cooperberg MR. PMID: 22332166.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    385. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):e787-93. Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M, Jung AJ, Carroll PR, Coakley FV. PMID: 22331003; PMCID: PMC3285390.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    386. Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management. Jpn J Clin Oncol. 2012 Mar; 42(3):226-36. Akaza H, Carroll P, Cooperberg MR, Hinotsu S. PMID: 22217576.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    387. Outcomes for radical prostatectomy: is it the singer, the song, or both? J Clin Oncol. 2012 Feb 10; 30(5):476-8. Cooperberg MR, Odisho AY, Carroll PR. PMID: 22215744.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    388. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing. Urol Oncol. 2012 Jan-Feb; 30(1):117-9. Messing EM, Albertsen P, Andriole GL, Carroll PR, Klein EA. PMID: 22243597.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    389. Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease. AJR Am J Roentgenol. 2011 Dec; 197(6):1369-74. Muglia VF, Westphalen AC, Wang ZJ, Kurhanewicz J, Carroll PR, Coakley FV. PMID: 22109291; PMCID: PMC3703946.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    390. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):189-94. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM. PMID: 22343837.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    391. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int. 2012 Jul; 110(1):50-5. Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR. PMID: 22077660.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    392. Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment. J Urol. 2011 Dec; 186(6):2228-32. Reese AC, Fradet V, Whitson JM, Davis CB, Carroll PR. PMID: 22014796.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    393. Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores? BJU Int. 2012 May; 109(10):1520-4. Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. PMID: 21999368; PMCID: PMC3288727.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    394. Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer. J Urol. 2011 Nov; 186(5):1825-9. Porten SP, Whitson JM, Cowan JE, Perez N, Shinohara K, Carroll PR. PMID: 21944082.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    395. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. PMID: 21934053; PMCID: PMC3831607.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansPHPublic Health
    396. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 21912659; PMCID: PMC3164676.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    397. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012 Jul 01; 131(1):201-10. Richman EL, Carroll PR, Chan JM. PMID: 21823116; PMCID: PMC3310254.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimals
    398. Androgen deprivation therapy and cardiovascular risk. J Clin Oncol. 2011 Sep 10; 29(26):3510-6. Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. PMID: 21844498; PMCID: PMC3179251.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    399. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011 Sep 20; 29(27):3669-76. Cooperberg MR, Carroll PR, Klotz L. PMID: 21825257.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansPHPublic Health
    400. Treatment trends for stage I renal cell carcinoma. J Urol. 2011 Aug; 186(2):394-9. Cooperberg MR, Mallin K, Kane CJ, Carroll PR. PMID: 21679982.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    401. The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study. J Urol. 2011 Aug; 186(2):465-9. McKenney JK, Simko J, Bonham M, True LD, Troyer D, Hawley S, Newcomb LF, Fazli L, Kunju LP, Nicolas MM, Vakar-Lopez F, Zhang X, Carroll PR, Brooks JD, Canary/Early Detection Research Network Prostate Active Surveillance Study Investigators. PMID: 21679996.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansPHPublic Health
    402. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011 Nov 15; 117(22):5039-46. Cooperberg MR, Hilton JF, Carroll PR. PMID: 21647869; PMCID: PMC3170662.
      View in: PubMed   Mentions: 171     Fields:    Translation:Humans
    403. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol. 2011 Jul 10; 29(20):2795-800. Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR. PMID: 21632511.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    404. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 01; 71(11):3889-95. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. PMID: 21610110; PMCID: PMC3107352.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    405. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol. 2011 Aug; 60(2):291-303. Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH. PMID: 21601982.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    406. Factors associated with downgrading in patients with high grade prostate cancer. Urol Oncol. 2013 May; 31(4):442-7. Whitson JM, Porten SP, Cowan JE, Simko JP, Cooperberg MR, Carroll PR. PMID: 21478037.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    407. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. 2011 Apr; 107(8):1232-7. Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll PR. PMID: 20804478.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    408. Editorial comment. Urology. 2011 Apr; 77(4):984-5. Carroll PR, Whitson JM. PMID: 21477729.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    409. The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol. 2011 May; 185(5):1656-60. Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll PR. PMID: 21419438.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansPHPublic Health
    410. Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol. 2011 May; 185(5):1631-6. Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM. PMID: 21419456.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    411. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. Cancer. 2011 Oct 01; 117(19):4406-13. Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR, Satariano W. PMID: 21412760.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    412. The example of CaPSURE: lessons learned from a national disease registry. World J Urol. 2011 Jun; 29(3):265-71. Porten SP, Cooperberg MR, Konety BR, Carroll PR. PMID: 21347810; PMCID: PMC3099175.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    413. Prostate cancer: reducing overtreatment: active surveillance in low-risk disease. Nat Rev Urol. 2011 Mar; 8(3):124-5. Whitson JM, Porten SP, Carroll PR. PMID: 21304508.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    414. The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study. J Clin Nurs. 2011 Feb; 20(3-4):581-6. Kazer MW, Bailey DE, Colberg J, Kelly WK, Carroll P. PMID: 21219530.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    415. Gentamicin pharmacokinetics in old age and frailty. Br J Clin Pharmacol. 2011 Feb; 71(2):224-31. Hilmer SN, Tran K, Rubie P, Wright J, Gnjidic D, Mitchell SJ, Matthews S, Carroll PR. PMID: 21219402; PMCID: PMC3040542.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    416. Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women. Urology. 2011 Apr; 77(4):878-83. Yang G, Whitson JM, Breyer BN, Konety BR, Carroll PR. PMID: 21215428; PMCID: PMC3607667.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    417. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? J Clin Oncol. 2011 Feb 01; 29(4):345-7. Carroll PR, Whitson JM, Cooperberg MR. PMID: 21189396.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    418. Urology resident publication output and its relationship to future academic achievement. J Urol. 2011 Feb; 185(2):642-6. Yang G, Zaid UB, Erickson BA, Blaschko SD, Carroll PR, Breyer BN. PMID: 21168863; PMCID: PMC3565588.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    419. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol. 2011 Jan 10; 29(2):235-41. Bechis SK, Carroll PR, Cooperberg MR. PMID: 21135285; PMCID: PMC3058279.
      View in: PubMed   Mentions: 138     Fields:    Translation:Humans
    420. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010 Dec; 106(11):1734-8. Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. PMID: 20438567; PMCID: PMC3565608.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    421. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol. 2011 Jan 10; 29(2):228-34. Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. PMID: 21115873; PMCID: PMC3058278.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    422. Inaccuracies in assignment of clinical stage for localized prostate cancer. Cancer. 2011 Jan 15; 117(2):283-9. Reese AC, Sadetsky N, Carroll PR, Cooperberg MR. PMID: 21210472.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    423. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res. 2011 Jan 15; 71(2):550-60. Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R. PMID: 21098088; PMCID: PMC3022112.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    424. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. PMID: 21103921; PMCID: PMC3002170.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    425. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. 2010 Nov 15; 116(22):5226-34. Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. PMID: 20690197; PMCID: PMC2975879.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    426. Disproportionate presentation of high risk prostate cancer in a safety net health system. J Urol. 2010 Nov; 184(5):1931-6. Porten SP, Richardson DA, Odisho AY, McAninch JW, Carroll PR, Cooperberg MR. PMID: 20846693.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    427. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int. 2010 Sep; 106(5):627-32. Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV. PMID: 20151961.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    428. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians. Urol Oncol. 2012 Mar-Apr; 30(2):155-60. Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan JM. PMID: 20800514.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    429. Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship. BMC Med Inform Decis Mak. 2010 Jun 17; 10:34. Vickers AJ, Salz T, Basch E, Cooperberg MR, Carroll PR, Tighe F, Eastham J, Rosen RC. PMID: 20565745; PMCID: PMC2893444.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    430. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 2010 Jul; 256(1):176-83. Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR. PMID: 20505068; PMCID: PMC2897693.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    431. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease. J Urol. 2010 Jul; 184(1):114-9. Reese AC, Cooperberg MR, Carroll PR. PMID: 20478578.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    432. Active surveillance for early-stage prostate cancer: defining the triggers for intervention. J Clin Oncol. 2010 Jun 10; 28(17):2807-9. Whitson JM, Carroll PR. PMID: 20439633.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    433. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010 May 01; 116(9):2140-7. Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll PR, Smith JF, Eisenberg ML, Van Den Eeden SK, Croughan MS. PMID: 20309846; PMCID: PMC2893877.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    434. Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo. Br J Cancer. 2010 May 11; 102(10):1474-82. Bright SA, McElligott AM, O'Connell JW, O'Connor L, Carroll P, Campiani G, Deininger MW, Conneally E, Lawler M, Williams DC, Zisterer DM. PMID: 20407438; PMCID: PMC2869169.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    435. Urologist density and county-level urologic cancer mortality. J Clin Oncol. 2010 May 20; 28(15):2499-504. Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR. PMID: 20406931; PMCID: PMC2881728.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    436. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer. 2010 Apr 15; 116(8):1901-8. Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR. PMID: 20186823.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    437. The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer. BJU Int. 2010 May; 105(10):1417-22. Katz MS, Efstathiou JA, D'Amico AV, Kattan MW, Sanda MG, Nguyen PL, Smith MR, Carroll PR, Zietman AL. PMID: 20346051; PMCID: PMC3090683.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    438. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol). 2010 May; 22(4):281-8. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E, Reynolds JV. PMID: 20189371.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    439. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int. 2010 Oct; 106(7):1022-9. Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR, CaPSURE Investigators. PMID: 20184571.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    440. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010 Mar 01; 28(7):1117-23. Cooperberg MR, Broering JM, Carroll PR. PMID: 20124165; PMCID: PMC2834465.
      View in: PubMed   Mentions: 401     Fields:    Translation:Humans
    441. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010 Feb; 8(2):240-62. Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT. PMID: 20141680.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    442. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010 Feb 20; 28(6):1069-74. Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA. PMID: 20100957; PMCID: PMC2834431.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    443. Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort. J Urol. 2010 Jan; 183(1):138-43. Smaldone MC, Cowan JE, Carroll PR, Davies BJ. PMID: 19913808.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    444. The impact of male circumcision on HIV transmission. J Urol. 2010 Jan; 183(1):21-6. Doyle SM, Kahn JG, Hosang N, Carroll PR. PMID: 19913816.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    445. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar; 91(3):712-21. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. PMID: 20042525; PMCID: PMC3132069.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    446. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed. 2010 May; 23(4):391-8. Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG. PMID: 20033906; PMCID: PMC2891902.
      View in: PubMed   Mentions: 19